vs
LiveRamp Holdings, Inc.（RAMP）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.0倍（$212.2M vs $207.3M），LiveRamp Holdings, Inc.净利率更高（18.8% vs -62.0%，领先80.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 8.6%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 11.1%）
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
RAMP vs RARE — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $212.2M | $207.3M |
| 净利润 | $39.9M | $-128.6M |
| 毛利率 | 71.9% | — |
| 营业利润率 | 18.6% | -54.7% |
| 净利率 | 18.8% | -62.0% |
| 营收同比 | 8.6% | 25.9% |
| 净利润同比 | 255.7% | 3.5% |
| 每股收益（稀释后） | $0.62 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $212.2M | $207.3M | ||
| Q3 25 | $199.8M | $159.9M | ||
| Q2 25 | $194.8M | $166.5M | ||
| Q1 25 | $188.7M | $139.3M | ||
| Q4 24 | $195.4M | $164.6M | ||
| Q3 24 | $185.5M | $139.5M | ||
| Q2 24 | $176.0M | $147.0M | ||
| Q1 24 | $171.9M | $108.8M |
| Q4 25 | $39.9M | $-128.6M | ||
| Q3 25 | $27.4M | $-180.4M | ||
| Q2 25 | $7.7M | $-115.0M | ||
| Q1 25 | $-6.3M | $-151.1M | ||
| Q4 24 | $11.2M | $-133.2M | ||
| Q3 24 | $1.7M | $-133.5M | ||
| Q2 24 | $-7.5M | $-131.6M | ||
| Q1 24 | $-5.4M | $-170.7M |
| Q4 25 | 71.9% | — | ||
| Q3 25 | 70.2% | — | ||
| Q2 25 | 70.1% | — | ||
| Q1 25 | 69.3% | — | ||
| Q4 24 | 71.9% | — | ||
| Q3 24 | 72.4% | — | ||
| Q2 24 | 70.6% | — | ||
| Q1 24 | 72.2% | — |
| Q4 25 | 18.6% | -54.7% | ||
| Q3 25 | 10.7% | -106.9% | ||
| Q2 25 | 3.7% | -64.8% | ||
| Q1 25 | -6.1% | -102.6% | ||
| Q4 24 | 7.5% | -74.3% | ||
| Q3 24 | 4.0% | -94.6% | ||
| Q2 24 | -3.0% | -79.1% | ||
| Q1 24 | -8.3% | -151.9% |
| Q4 25 | 18.8% | -62.0% | ||
| Q3 25 | 13.7% | -112.8% | ||
| Q2 25 | 4.0% | -69.0% | ||
| Q1 25 | -3.3% | -108.5% | ||
| Q4 24 | 5.7% | -80.9% | ||
| Q3 24 | 0.9% | -95.7% | ||
| Q2 24 | -4.3% | -89.5% | ||
| Q1 24 | -3.1% | -156.8% |
| Q4 25 | $0.62 | $-1.28 | ||
| Q3 25 | $0.42 | $-1.81 | ||
| Q2 25 | $0.12 | $-1.17 | ||
| Q1 25 | $-0.10 | $-1.57 | ||
| Q4 24 | $0.17 | $-1.34 | ||
| Q3 24 | $0.03 | $-1.40 | ||
| Q2 24 | $-0.11 | $-1.52 | ||
| Q1 24 | $-0.09 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $403.4M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $962.3M | $-80.0M |
| 总资产 | $1.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $403.4M | $421.0M | ||
| Q3 25 | $376.9M | $202.5M | ||
| Q2 25 | $371.1M | $176.3M | ||
| Q1 25 | $420.8M | $127.1M | ||
| Q4 24 | $384.3M | $174.0M | ||
| Q3 24 | $348.4M | $150.6M | ||
| Q2 24 | $342.7M | $480.7M | ||
| Q1 24 | $368.9M | $112.3M |
| Q4 25 | $962.3M | $-80.0M | ||
| Q3 25 | $943.8M | $9.2M | ||
| Q2 25 | $947.8M | $151.3M | ||
| Q1 25 | $948.9M | $144.2M | ||
| Q4 24 | $957.7M | $255.0M | ||
| Q3 24 | $932.1M | $346.8M | ||
| Q2 24 | $951.9M | $432.4M | ||
| Q1 24 | $949.1M | $140.3M |
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.3B | $1.5B | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | $1.2B | $1.6B | ||
| Q1 24 | $1.2B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | 0.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $57.4M | $-91.4M | ||
| Q2 25 | $-15.8M | $-108.3M | ||
| Q1 25 | — | $-166.5M | ||
| Q4 24 | $45.1M | $-79.3M | ||
| Q3 24 | $55.6M | $-67.0M | ||
| Q2 24 | $-9.3M | $-77.0M | ||
| Q1 24 | — | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $56.8M | $-92.7M | ||
| Q2 25 | $-16.2M | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | $44.8M | $-79.5M | ||
| Q3 24 | $55.4M | $-68.6M | ||
| Q2 24 | $-9.6M | $-79.0M | ||
| Q1 24 | — | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | 28.4% | -58.0% | ||
| Q2 25 | -8.3% | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | 22.9% | -48.3% | ||
| Q3 24 | 29.8% | -49.2% | ||
| Q2 24 | -5.4% | -53.7% | ||
| Q1 24 | — | -178.2% |
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.2% | 1.0% | ||
| Q4 24 | 0.1% | 0.1% | ||
| Q3 24 | 0.1% | 1.2% | ||
| Q2 24 | 0.1% | 1.4% | ||
| Q1 24 | 1.0% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 2.09× | — | ||
| Q2 25 | -2.04× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.02× | — | ||
| Q3 24 | 32.10× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RAMP
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
